New pain drug tested on healthy volunteers

NCT ID NCT06742840

Summary

This early-stage study aimed to check the safety and basic effects of a new pain medication called HRS-2129. It involved 23 healthy adults who received the drug and underwent tests to see how it changed their sensitivity to hot and cold pain. The main goal was to see if the drug was safe and how the body processed it, not to treat existing pain.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, 410013, China

Conditions

Explore the condition pages connected to this study.